Your browser doesn't support javascript.
loading
Butein inhibits cancer cell growth by rescuing the wild-type thermal stability of mutant p53.
Song, Bin; Wang, Jiajian; Ren, Yixin; Su, Yongnan; Geng, Xueye; Yang, Fan; Wang, Hao; Zhang, Jihong.
Afiliación
  • Song B; Lab of Molecular Pharmacology, Medical School, Kunming University of Science and Technology, Kunming 650500, China; Laboratory of Radiation Medicine, West China Second University Hospital, Sichuan University, Chengdu 610041, China.
  • Wang J; Lab of Molecular Pharmacology, Medical School, Kunming University of Science and Technology, Kunming 650500, China.
  • Ren Y; School of Pharmacy, Minzu University of China, Beijing 100081, China.
  • Su Y; Lab of Molecular Pharmacology, Medical School, Kunming University of Science and Technology, Kunming 650500, China.
  • Geng X; Lab of Molecular Pharmacology, Medical School, Kunming University of Science and Technology, Kunming 650500, China.
  • Yang F; Lab of Molecular Pharmacology, Medical School, Kunming University of Science and Technology, Kunming 650500, China.
  • Wang H; School of Pharmacy, Minzu University of China, Beijing 100081, China.
  • Zhang J; Lab of Molecular Pharmacology, Medical School, Kunming University of Science and Technology, Kunming 650500, China; Yunnan Province Clinical Research Center for Hematologic Disease, Kunming 650032, China. Electronic address: zhjihong2000@kust.edu.cn.
Biomed Pharmacother ; 163: 114773, 2023 Jul.
Article en En | MEDLINE | ID: mdl-37156116
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Transformación Celular Neoplásica / Proteína p53 Supresora de Tumor Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Biomed Pharmacother Año: 2023 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Transformación Celular Neoplásica / Proteína p53 Supresora de Tumor Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Biomed Pharmacother Año: 2023 Tipo del documento: Article País de afiliación: China